catechin has been researched along with Cerebral Infarction in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, JB; Koh, PO; Park, DJ | 1 |
| Aggarwal, R; Chakrabarti, A; Kaur, H; Kumar, B; Medhi, B; Modi, M; Radotra, BD; Sinha, VR | 1 |
| Ahmad, A; Ahmad, ME; Ashafaq, M; Islam, F; Javed, H; Khan, MM; Raza, SS; Safhi, MM; Siddiqui, MS; Tabassum, R | 1 |
| Cai, F; Chen, JG; Chen, JH; Li, CR; Liu, C; Min, Q; Ouyang, CH; Wu, JL; Yu, W | 1 |
| Cai, F; Li, C; Lin, F; Ma, S; Min, Q; Ouyang, C; Wu, J; Yu, W; Zheng, M | 1 |
| Borzeix, MG; Cahn, J | 1 |
6 other study(ies) available for catechin and Cerebral Infarction
| Article | Year |
|---|---|
Epigallocatechin gallate alleviates neuronal cell damage against focal cerebral ischemia in rats.
Topics: Animals; Apoptosis; Brain Ischemia; Caspase 3; Catechin; Cerebral Infarction; Disease Models, Animal; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Poly(ADP-ribose) Polymerases; Rats, Sprague-Dawley | 2020 |
A New Therapeutic Approach for Brain Delivery of Epigallocatechin Gallate: Development and Characterization Studies.
Topics: Animals; Behavior, Animal; Biological Availability; Blood-Brain Barrier; Catechin; Cerebral Infarction; Disease Models, Animal; Drug Compounding; Drug Liberation; Emulsions; Humans; Lipids; Male; Memory Disorders; Mice; Nanoparticles; Neuroprotective Agents; Treatment Outcome | 2019 |
Catechin hydrate ameliorates redox imbalance and limits inflammatory response in focal cerebral ischemia.
Topics: Animals; Antioxidants; Behavior, Animal; Brain; Brain Ischemia; Catechin; Cerebral Infarction; Glial Fibrillary Acidic Protein; Glutathione; Infarction, Middle Cerebral Artery; Male; NF-kappa B; Nitric Oxide Synthase Type II; Oxidation-Reduction; Rats; Rats, Wistar; Reperfusion Injury; Thiobarbituric Acid Reactive Substances | 2012 |
Theaflavin ameliorates cerebral ischemia-reperfusion injury in rats through its anti-inflammatory effect and modulation of STAT-1.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biflavonoids; Brain Edema; Brain Ischemia; Catechin; Cerebral Infarction; Cyclooxygenase 2; Inflammation Mediators; Intercellular Adhesion Molecule-1; Male; Malondialdehyde; Nitric Oxide Synthase Type II; Phosphorylation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; RNA, Messenger; STAT1 Transcription Factor | 2006 |
Modulation of the oxidative stress and nuclear factor kappaB activation by theaflavin 3,3'-gallate in the rats exposed to cerebral ischemia-reperfusion.
Topics: Animals; Biflavonoids; Brain; Brain Ischemia; Catechin; Cell Extracts; Cerebral Infarction; Cyclooxygenase 2; Gallic Acid; Gene Expression Regulation, Enzymologic; Glutathione Peroxidase; I-kappa B Proteins; Lipid Peroxidation; Malondialdehyde; Nervous System Diseases; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Rats; Reperfusion Injury; Superoxide Dismutase | 2007 |
[Administration of procyanidolic oligomers in rats. Observed effects on changes in the cerebral biochemistry, secondary to multiple infarction].
Topics: Animals; Arachidonic Acids; Behavior, Animal; Benzopyrans; Biflavonoids; Brain; Catechin; Cerebral Infarction; Male; Proanthocyanidins; Rats; Rats, Inbred Strains | 1983 |